303 related articles for article (PubMed ID: 31419515)
1. Natural history of liver adenomatosis: A long-term observational study.
Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
[TBL] [Abstract][Full Text] [Related]
2. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.
Hahn E; Putra J
World J Gastroenterol; 2020 May; 26(19):2294-2304. PubMed ID: 32476794
[TBL] [Abstract][Full Text] [Related]
4. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
7. Molecular classification of hepatocellular adenoma in clinical practice.
Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
[TBL] [Abstract][Full Text] [Related]
8. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
10. Large Hepatic Adenomas and Hepatic Adenomatosis: A Multicenter Study of Risk Factors, Interventions, and Complications.
Lammert C; Toal E; Mathur K; Khungar V; House M; Roberts LR; Reddy KR; Chalasani N
Am J Gastroenterol; 2022 Jul; 117(7):1089-1096. PubMed ID: 35333776
[TBL] [Abstract][Full Text] [Related]
11. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
[TBL] [Abstract][Full Text] [Related]
12. European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.
Laurent A; Dokmak S; Nault JC; Pruvot FR; Fabre JM; Letoublon C; Bachellier P; Capussotti L; Farges O; Mabrut JY; Le Treut YP; Ayav A; Suc B; Soubrane O; Mentha G; Popescu I; Montorsi M; Demartines N; Belghiti J; Torzilli G; Cherqui D; Hardwigsen J;
HPB (Oxford); 2016 Sep; 18(9):748-55. PubMed ID: 27593592
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.
Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.
Julien C; Le-Bail B; Ouazzani Touhami K; Frulio N; Blanc JF; Adam JP; Laurent C; Balabaud C; Bioulac-Sage P; Chiche L
Ann Surg; 2021 Nov; 274(5):843-850. PubMed ID: 34334644
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for bleeding hepatocellular adenoma in a United States cohort.
McDermott C; Ertreo M; Jha R; Ko J; Fernandez S; Desale S; Fishbein T; Satoskar R; Winslow E; Smith C; Hsu CC
Liver Int; 2022 Jan; 42(1):224-232. PubMed ID: 34687281
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular adenoma: An unsolved diagnostic enigma.
Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular adenomatosis: what should the term stand for!
Frulio N; Chiche L; Bioulac-Sage P; Balabaud C
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):132-6. PubMed ID: 24126236
[TBL] [Abstract][Full Text] [Related]
19. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
